Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yang, Fenge
NCT06142552: Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Recruiting	3	120	RoW	FRSW117, Recombinant human coagulation factor Ⅷ-Fc fusion protein for injection	Jiangsu Gensciences lnc.	Severe Hemophilia A	01/26	09/26
NCT06900920: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia	Not yet recruiting	3	199	RoW	TQB3473 Tablets, TQB3473 Placebo	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Primary Immune Thrombocytopenia	03/27	12/27
NCT05707832: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus	Completed	3	31	RoW	Amphotericin B cholesteryl Sulfate Complex for Injection	CSPC Ouyi Pharmaceutical Co., Ltd.	Invasive Candidiasis, Invasive Aspergillosis	07/24	03/25
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia	Recruiting	3	195	RoW	Orelabrutinib, Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Chronic Primary Immune Thrombocytopenia (ITP)	12/25	04/26
STSP-0601-04, NCT06289166: Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor	Completed	2	25	RoW	STSP-0601 for Injection	Staidson (Beijing) Biopharmaceuticals Co., Ltd	Hemophilia	10/24	10/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yang, Fenge
NCT06142552: Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein	Recruiting	3	120	RoW	FRSW117, Recombinant human coagulation factor Ⅷ-Fc fusion protein for injection	Jiangsu Gensciences lnc.	Severe Hemophilia A	01/26	09/26
NCT06900920: A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia	Not yet recruiting	3	199	RoW	TQB3473 Tablets, TQB3473 Placebo	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Primary Immune Thrombocytopenia	03/27	12/27
NCT05707832: A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus	Completed	3	31	RoW	Amphotericin B cholesteryl Sulfate Complex for Injection	CSPC Ouyi Pharmaceutical Co., Ltd.	Invasive Candidiasis, Invasive Aspergillosis	07/24	03/25
NCT06004856: Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia	Recruiting	3	195	RoW	Orelabrutinib, Placebo	Beijing InnoCare Pharma Tech Co., Ltd.	Chronic Primary Immune Thrombocytopenia (ITP)	12/25	04/26
STSP-0601-04, NCT06289166: Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor	Completed	2	25	RoW	STSP-0601 for Injection	Staidson (Beijing) Biopharmaceuticals Co., Ltd	Hemophilia	10/24	10/24